z-logo
open-access-imgOpen Access
Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge
Author(s) -
Emilie R Elliot,
Alieu Amara,
Nicole Pagani,
Laura Else,
Graeme Moyle,
Alex Schoolmeesters,
Chris Higgs,
Saye Khoo,
Marta Boffito
Publication year - 2017
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkx145
Subject(s) - cobicistat , atazanavir , darunavir , pharmacokinetics , pharmacology , medicine , urine , ritonavir , saliva , virology , human immunodeficiency virus (hiv) , antiretroviral therapy , viral load

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom